Home › Non-Small Cell Lung Cancer › Florida › Sarasota
Non-Small Cell Lung Cancer clinical trials in Sarasota, FL
17 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RecruitingPhase 1
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecruitingPhase 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Local Institution - 007-922-I, Sarasota
- Local Institution - 007-922-J, Sarasota
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Florida Cancer Specalists, Sarasota
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Sarasota
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Sarasota
- Metastatic Cancer19 studies
- Ovarian Cancer16 studies
- Colorectal Cancer15 studies
- Endometrial Cancer15 studies
- Breast Cancer12 studies
- Cancer (all types)11 studies
- Triple-Negative Breast Cancer8 studies
- Atrial Fibrillation7 studies
- Lung Cancer7 studies
- Pancreatic Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Steatotic Liver Disease6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.